P696: SUBTHERAPEUTIC TKI DOSES FOR THE MAINTENANCE OF CML PATIENTS WITH INTOLERANCE OR REFUSAL TO DISCONTINUE: A SINGLE CENTER FEASIBILITY STUDY.

oleh: A. Borrero, A. Segura, S. Sanchez, R. Stuckey, J. F. López, C. Bilbao, M. T. Gomez casares

Format: Article
Diterbitkan: Wiley 2022-06-01

Deskripsi

No description available for this item.